Download Files:
PM-43I
SKU
HY-148092-10 mg
Category Reference compound
Tags Cancer; Inflammation/Immunology, JAK/STAT Signaling;Stem Cell/Wnt, STAT
$826 – $5,000
Products Details
Product Description
– PM-43I is a potent STAT6 inhibitor and can reduce STAT6 phosphorylation level. PM-43I can be used in allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease and cancer research[1].
Web ID
– HY-148092
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C38H50F2N3O10P
References
– [1]John S. Mcmurray, et al. Stat6 inhibitors. WO2014182928A2.
CAS Number
– 1637532-77-4
Molecular Weight
– 777.79
Compound Purity
– 99.75
SMILES
– CC(C)(C)C(OCOP(C(F)(C1=CC=C(C=C1)/C(C)=C/C(N[C@@H]2C(N(CCCC2)CC(N(C3=CC=CC=C3)C)=O)=O)=O)F)(OCOC(C(C)(C)C)=O)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– DMSO : 35 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– STAT
Pathway
– JAK/STAT Signaling;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.